Intuitive Surgical Inc (ISRG): Salvatore Brogna , EVP – Product Operations of Intuitive Surgical Inc sold 600 shares on Jun 2, 2016. The Insider selling transaction was reported by the company on Jun 3, 2016 to the Securities and Exchange Commission. The shares were sold at $630.96 per share for a total value of $378,576.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 2, 2016, Salvatore Brogna (EVP – Product Operations) sold 20,406 shares at $631.72 per share price.On May 18, 2016, Curet Myriam (SVP & Chief Medical Officer) sold 530 shares at $629.36 per share price.Also, On May 18, 2016, Lonnie M Smith (director) sold 2,000 shares at $627.23 per share price.On May 4, 2016, George Jr Stalk (director) sold 7,644 shares at $618.70 per share price.
Shares of Intuitive Surgical (ISRG) ended Friday, Jun 3, 2016 session in red amid volatile trading. The shares closed down -2.6 points or -0.41% at $636.84 with 2,46,909 shares getting traded. Post opening the session at $639.41, the shares hit an intraday low of $632.57 and an intraday high of $639.54 and the price vacillated in this range throughout the day. The company has a market cap of $24,238 M and the number of outstanding shares has been calculated to be 3,80,60,364 shares. The 52-week high of Intuitive Surgical is $654.88 and the 52-week low is $447.
Company has been under the radar of several Street Analysts.Intuitive Surgical is Downgraded by Goldman to Neutral. Earlier the firm had a rating of Buy on the company shares. The Rating was issued on Jun 2, 2016.Intuitive Surgical is Reiterated by RBC Capital Mkts to Sector Perform and the brokerage firm has raised the Price Target to $ 640 from a previous price target of $610 .The Rating was issued on Apr 20, 2016.Intuitive Surgical is Reiterated by Stifel to Buy and the brokerage firm has raised the Price Target to $ 700 from a previous price target of $640 .The Rating was issued on Apr 20, 2016.Intuitive Surgical is Reiterated by Piper Jaffray to Neutral and the brokerage firm has raised the Price Target to $ 610 from a previous price target of $550 .The Rating was issued on Apr 20, 2016.Intuitive Surgical is Reiterated by Leerink Partners to Outperform and the brokerage firm has raised the Price Target to $ 710 from a previous price target of $700 .The Rating was issued on Apr 20, 2016.
Intuitive Surgical Inc. designs manufactures and markets da Vinci Surgical Systems and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console a patient-side cart and vision system. The da Vinci Surgical System provides its operating surgeons with control range of motion tissue manipulation and three-dimensional (3-D) high-definition (HD) vision. It allows surgeons to work through the small ports enabled by minimally invasive surgery (MIS) procedures. Its da Vinci Surgery utilizes computational robotic and imaging technologies. The Company has four generations of da Vinci Surgical System: the da Vinci Xi Surgical System the da Vinci Si Surgical System the da Vinci S Surgical System and the standard da Vinci Surgical System. The Company focuses on five surgical specialties: urologic surgery gynecologic surgery general surgery cardiothoracic surgery and head and neck surgery.